Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- SFIX +12.5%, SAIL +10.6%, PLAY +7.1%
Other news:
- XNET +8.7% (investee company completes IPO on Shanghai Stock Exchange STAR Market)
- NMG +7.6% (firming up its project debt financing structure with the intended participation of syndicate institutional funds and export credit agencies for over US$1 billion toward the Company's Phase-2 Matawinie Mine and Bécancour Battery Material Plant)
- SSTK +7.1% (GETY SSTK merger proposal approved by shareholders)
- GETY +5.9% (GETY SSTK merger proposal approved by shareholders)
- CLDX +4.6% (announces presentations of Barzolvolimab Phase 2 Data)
- CXW +2.7% (to acquire the Farmville Detention Center)
- MXCT +2.6% (MaxCyte and Ori Biotech successfully integrate their ExPERT and IRO platforms to improve the yield of gene-edited T cells and shorten manufacturing timelines)
- CRVS +2.3% (presents soquelitinib preclinical data highlighting potential of ITK inhibition to treat systemic sclerosis at EULAR 2025 Congress)
- VTS +2.1% (CEO bought 10000 shares)
- MT +1.8% (US, Mexico nearing deal on steel duties, according to Bloomberg)
- IPX +1.8% (has received the first task order, valued at $1.3 million, from the U.S. Army)
- DNUT +1.7% (sells remaining stake in Insomnia Cookies)
- AB +1.5% (reports May AUM)
- INMB +1.5% (presents data from study)
- NVAX +1% (Co's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial)